In 1957, shepherds in Idaho (USA) discovered that when pregnant sheep ate lilies of the species Veratrum californicum (corn lily, California false hellebore), their lambs were born with only one eye in the center of their foreheads, like a cyclops.
The trigger for this was found to be the alkaloid cyclopamine. Cyclopamine has proven to be an effective candidate for cancer therapy in adult humans and is now undergoing clinical trials. A research team at the Universities of Leipzig (Germany) and Thessaloniki (Greece) has now developed a new synthetic pathway for the production of cyclopamine.
As they report in the journal Angewandte Chemie, the scientists, led by Athanassios Giannis, are confident that their research results will help to broaden our understanding of the structure–activity relationships of cyclopamine and to develop cyclopamine analogues with tuned bioactivities.
Cyclopamine is the first inhibitor of the hedgehog signal-transduction pathway, which is used by cells to react to external signals. The signaling pathway is named for its ligand “hedgehog”, a signal protein that carries out an important function in embryonic development. Malfunction of this signaling pathway leads to massive deformations in the course of embryonic development, such as cyclopia, and can cause cancer in adults. Inhibition of this pathway is a new possible cancer treatment.
Until now, there has been no efficient synthesis for cyclopamine. The structure of this unusual steroidal alkaloid contains many peculiarities that make synthesis difficult. The German and Greek team has now overcome these difficulties to develop an efficient twenty-step synthetic strategy starting from commercially available dehydroepiandrosterone, a natural steroid hormone. The strategy is based on biomimetic and diastereoselective transformations. The researchers achieved an overall yield of 1 %, which is a good result for such a tricky synthesis. In addition, small modifications in the reagents used allow this strategy to be used to produce cyclopamine analogues that do not occur in nature. The scientists aim to use these analogues to further examine the biological activity of this interesting natural product and then to adjust the activity to develop a new anti-tumor agent.Author: Athanassios Giannis, Universität Leipzig (Germany),
Angewandte Chemie International Edition, doi: 10.1002/anie.200902520
Mass spectrometry sheds new light on thallium poisoning cold case
14.12.2018 | University of Maryland
Protein involved in nematode stress response identified
14.12.2018 | University of Illinois College of Agricultural, Consumer and Environmental Sciences
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
14.12.2018 | Power and Electrical Engineering
14.12.2018 | Physics and Astronomy
14.12.2018 | Physics and Astronomy